Los Angeles Capital Management LLC Rapt Therapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.2 Billion
- Q4 2024
A detailed history of Los Angeles Capital Management LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 219,997 shares of RAPT stock, worth $274,996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
219,997
Previous 201,439
9.21%
Holding current value
$274,996
Previous $404,000
14.11%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$27.9 Million7.76% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$16.4 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$16.4 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$15.6 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$14.7 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $37.1M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...